← Back
$APLS All transactions

Apellis Pharmaceuticals, Inc.

▼ SELL

$ Value

$44K

Shares

2,203

Price

$20

Filed

Jan 21

Insider

Name

Nicholson Nur

Title

Chief Technical Officer

CIK

0001827317

Roles

Officer

Transaction Details

Transaction Date

2026-01-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

78,843

Footnotes

This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 16, 2026.

Filing Info

Accession No.

0001492422-26-000040

Form Type

4

Issuer CIK

0001492422

Nicholson Nur's History

Date Ticker Type Value
2026-01-28 APLS A $0
2026-01-22 APLS $168K
2026-01-20 APLS $44K
2026-01-13 APLS $58K
2025-06-09 APLS A $1.6M

Other Insiders at APLS (90d)

Insider Bought Sold Last
Dolsten Mikael 2026-02-27
Watson David O.
General Counsel
2026-01-28
Deschatelets Pascal
Chief Scientific Officer
2026-01-28
Francois Cedric
Chief Executive Officer
2026-03-11
Sullivan Timothy Eugene
Chief Financial Officer
2026-04-17
O'Brien Stephanie Monaghan 2026-04-06
Nicholson Nur
Chief Technical Officer
2026-01-28
Chopas James George
VP/Chief Accounting Officer
2026-01-28
DeLong Mark Jeffrey
Chief Business & Strat Officer
$8K 2026-02-11
Boucher Kelley
Chief People Officer
2026-01-28
MELTZER LESLIE
Chief Research and Development
2026-01-28